Switch to:
More From Other Websites
Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of... Jul 11 2016
Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of... Jul 11 2016
Myriad Genetics myChoice Cancer Test Findings Encourage Jul 01 2016
Myriad Genetics: Study Data Drives Growth, Competition Rife Jul 01 2016
MYRIAD GENETICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 30 2016
MYRIAD GENETICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 29 2016
Myriad's myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in TESARO's... Jun 29 2016
Myriad’s myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in... Jun 29 2016
Crescendo Bioscience Announces that New Data on Vectra® DA Will Be Presented at the European League... Jun 10 2016
MYRIAD GENETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 07 2016
Myriad Gets $200 Million More For Share Repurchase Program Jun 07 2016
Myraid Genetics increases share buyback program by $200 million Jun 07 2016
Myriad Board Approves $200 Million Increase in Share Repurchase Program Jun 07 2016
Myriad Board Approves $200 Million Increase in Share Repurchase Program Jun 07 2016
Myriad Genetics to Present at the 2016 Goldman Sachs Healthcare Conference Jun 06 2016
Myriad myRisk® Hereditary Cancer Test Demonstrates the Magnitude of Breast and Ovarian Cancer Risk... Jun 06 2016
Myriad Will Present Three New Hereditary Cancer Studies at the ASCO Annual Meeting Jun 05 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK